Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

Press releases published on June 22, 2026

12 minutes ago

Marius Pharmaceuticals Applauds FDA’s Proposed Testosterone Labeling Updates as a Turning Point for Men’s Health

Indeterminate GlobeNewswire

12 minutes ago

INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure

Indeterminate GlobeNewswire

13 minutes ago

Parexel Launches Parexel Biotech Incubator to Connect Early-Stage Innovation with Clinical Development Expertise

Indeterminate GlobeNewswire

22 minutes ago

InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds

Indeterminate GlobeNewswire

27 minutes ago

AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series

Indeterminate GlobeNewswire

27 minutes ago

Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion

Indeterminate GlobeNewswire

42 minutes ago

Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

Indeterminate GlobeNewswire

42 minutes ago

Next-Generation DNA Repair Therapies Open New Frontiers in Oncology

Indeterminate GlobeNewswire

42 minutes ago

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis

Indeterminate GlobeNewswire

42 minutes ago

FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing

Indeterminate GlobeNewswire

42 minutes ago

Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis

Indeterminate GlobeNewswire

42 minutes ago

NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization

Indeterminate GlobeNewswire

42 minutes ago

Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity

Indeterminate GlobeNewswire

an hour ago

Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial

Indeterminate GlobeNewswire

an hour ago

Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts 

Indeterminate GlobeNewswire

an hour ago

Novel Key Terms For Managing CIDP Published in Neurology® Journal

Indeterminate GlobeNewswire

an hour ago

Medidata Unveils New Academic Board to Bridge the Gap Between Research and Patient Care

Indeterminate GlobeNewswire

an hour ago

Kyverna Therapeutics Appoints Ritesh Srivastava as Chief Legal and Compliance Officer, Adding Leadership Strength to Support Commercial-Stage Transition

Indeterminate GlobeNewswire

an hour ago

GuideAI Health Receives FDA 510(k) Clearance for VascularAssist Occlusion Triage

Indeterminate GlobeNewswire

an hour ago

Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change

Indeterminate GlobeNewswire